Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Lepr^db/db mice

Medicine & Life Sciences

• INO 1001 100%
• N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride 86%
• Poly(ADP-ribose) Polymerase Inhibitors 79%
• Diabetic Nephropathies 63%
• Podocytes 61%
• Poly(ADP-ribose) Polymerases 59%
• Hyperglycemia 54%
• poly(ADP)-ribosylated proteins 37%
• Reactive Oxygen Species 15%
• Type 2 Diabetes Mellitus 14%
• Drinking Water 9%
• In Vitro Techniques 8%
• Albumins 8%
• Theoretical Models 8%
• Oxidative Stress 7%
• Phosphorylation 6%
• Glucose 6%
• Apoptosis 6%
• Kidney 5%